Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice

This publication has 17 references indexed in Scilit:

• Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG)
  European Journal of Gastroenterology & Hepatology, 1999
• Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome
  Journal of Clinical Oncology, 1999
• Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG)
  British Journal of Cancer, 1999
• Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours
  European Journal Of Cancer, 1996
• Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.
  Gut, 1996
• Neuroendocrine gastrointestinal tumours
  Annals of Oncology, 1996
• The Human Carcinoid Cell Line, BON
  Annals of the New York Academy of Sciences, 1994
• Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours
  European Journal of Nuclear Medicine and Molecular Imaging, 1994
• Diagnosis and Treatment of a Carcinoid Tumor Using lodine-131 Meta-iodobenzylguanidine
  Clinical Nuclear Medicine, 1986
• SCINTIGRAPHIC IMAGING OF CARCINOID TUMOURS WITH 131I-METAIODOBENZYLGUANIDINE
  The Lancet, 1984